Hygrovest Ltd

  • IPO date:
  • Sector: Healthcare
  • GIC Group: Pharmaceuticals, Biotechnology & Life Sciences
  • Industry: Drug Manufacturers-Specialty & Generic
  • Company website

Company description

Hygrovest Limited operates as a specialist investment company. It focuses on producing capital growth for shareholders over the medium to long term from investments in listed and unlisted securities and other debt securities. The company was formerly known as MMJ Group Holdings Limited and changed its name to Hygrovest Limited in December 2021. Hygrovest Limited was incorporated in 2014 and is headquartered in Sydney, Australia.

Financial highlights

Market Capitalization$11.1465 million
P/E Ratio0
P/E Growth Ratio
Book Value0.109
Dividend Per Share0
Earnings Per Share-0.05
EBITDA-10,389.5
Profit Margin0
Operating Margin TTM1.1732
Return on Assets TTM-0.198
Return on Equity TTM-0.3346
Revenue TTM-8,863

Income statement highlights

All numbers are in thousands

Date Total Revenue Cost of Revenue Gross Profit Total Operating Expenses
2017-06-30 122 102 20
2018-06-30 436 724 -288
2019-06-30 129 2,728
2020-06-30 843 1,645
2021-06-30 -70 -70 1,616
2022-06-30 657 1,464
2023-06-30 187 -9

Balance sheet highlights

All numbers are in thousands

Date Cash Total Assets Total Liabilities Short Term Debt Long Term Debt Common Stock
2017-06-30 47,243 17,178 0 0 44,954
2018-06-30 65,036 1,289 0 49,064
2019-06-30 26,392 95,660 10,022 0 52,936
2020-06-30 1,042 45,618 1,370 0 51,786
2021-06-30 3,445 43,565 3,313 0 51,786
2022-06-30 6,319 26,351 2,001 0 51,786
2023-06-30 3,715 21,964 2,584 0 50,746

Cash flow highlights

All numbers are in thousands

Date Net Income Total Cash Change in Cash Begin period cash End period cash Dividends
2017-06-30 -7,571 20,850
2018-06-30 -8,267 -22,454 1,347
2019-06-30 21,620 24,278 25,045 1,347 26,392
2020-06-30 -40,082 -24,444 -25,350 26,392 1,042
2021-06-30 -4,024 2,362 2,403 1,042 3,445
2022-06-30 -15,932 2,844 2,874 3,445 6,319
2023-06-30 -3,984 -1,528 -2,604 6,319 3,715